Angst, J, Clayton, P (1986). Premorbid personality of depressive, bipolar, and schizophrenic patients with special reference to suicidal issues. Comprehensive Psychiatry 27, 511–532.
Avramopoulos, D, Stefanis, NC, Hantoumi, I, Smyrnis, N, Evdokimidis, I, Stefanis, CN (2002). Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Molecular Psychiatry 7, 706–711.
Bagby, RM, Bindseil, KD, Schuller, DR, Rector, NA, Young, LT, Cooke, RG, Seeman, MV, McCay, EA, Joffe, R T (1997). Relationship between the five-factor model of personality and unipolar, bipolar and schizophrenic patients. Psychiatry Research 70, 83–94.
Benson, MA, Newey, SE, Martin-Rendon, E, Hawkes, R, Blake, DJ (2001). Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. Journal of Biological Chemistry 276, 24232–24241.
Berenbaum, H, Fujita, F (1994). Schizophrenia and personality: exploring the boundaries and connections between vulnerability and outcome. Journal of Abnormal Psychology 103, 148–158.
Blake, DJ, Hawkes, R, Benson, MA, Beesley, PW (1999). Different dystrophin-like complexes are expressed in neurons and glia. Journal of Cell Biology 147, 645–658.
Borkenau, P, Ostendorf, F (1993). The NEO Five-Factor Inventory (NEO-FFI) [NEO Fünf-Faktoren Inventar]. Hogrefe: Göttingen.
Brickenkamp, R (2002). The d2 Test of Attention [Der Aufmerksamkeits-Belastungstest d2]. Hogrefe: Göttingen.
Burdick, KE, Goldberg, TE, Funke, B, Bates, JA, Lencz, T, Kucherlapati, R, Malhotra, AK (2007). DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophrenia Research 89, 169–172.
Burdick, KE, Hodgkinson, CA, Szeszko, PR, Lencz, T, Ekholm, JM, Kane, JM, Goldman, D, Malhotra, AK (2005). DISC1 and neurocognitive function in schizophrenia. Neuroreport 16, 1399–1402.
Burdick, KE, Lencz, T, Funke, B, Finn, CT, Szeszko, PR, Kane, JM, Kucherlapati, R, Malhotra, AK (2006). Genetic variation in DTNBP1 influences general cognitive ability. Human Molecular Genetics 15, 1563–1568.
Camisa, KM, Bockbrader, MA, Lysaker, P, Rae, LL, Brenner, CA, O'Donnell, BF (2005). Personality traits in schizophrenia and related personality disorders. Psychiatry Research 133, 23–33.
Costa, PT, McCrae, RR (1992). NEO-PI-R: Professional Manual. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI). Psychological Assessment Resources: Odessa, FL.
Costa, PT Jr., McCrae, RR (1995). Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. Journal of Personality Assessment 64, 21–50.
Coyle, JT (2006). Glutamate and schizophrenia: beyond the dopamine hypothesis. Cellular and Molecular Neurobiology 26, 365–384.
Datta, SR, McQuillin, A, Puri, V, Choudhury, K, Thirumalai, S, Lawrence, J, Pimm, J, Bass, N, Lamb, G, Moorey, H, Morgan, J, Punukollu, B, Kandasami, G, Kirwin, S, Sule, A, Quested, D, Curtis, D, Gurling, HM (2007). Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behavioral and Brain Functions 3, 50.
Daum, I, Graber, S, Schugens, MM, Mayes, AR (1996). Memory dysfunction of the frontal type in normal ageing. Neuroreport 7, 2625–2628.
DeRosse, P, Funke, B, Burdick, KE, Lencz, T, Ekholm, JM, Kane, JM, Kucherlapati, R, Malhotra, AK (2006). Dysbindin genotype and negative symptoms in schizophrenia. American Journal of Psychiatry 163, 532–534.
Digman, JM (1990). Personality structure: emergence of the five-factor model. Annual Review of Psychology 41, 417–440.
Donohoe, G, Morris, DW, Clarke, S, McGhee, KA, Schwaiger, S, Nangle, JM, Garavan, H, Robertson, IH, Gill, M, Corvin, A (2007). Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 45, 454–458.
Fanous, AH, Neale, MC, Gardner, CO, Webb, BT, Straub, RE, O'Neill, FA, Walsh, D, Riley, BP & Kendler, KS (2007). Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Molecular Psychiatry 12, 958–965.
Fanous, AH, van den Oord, EJ, Riley, BP, Aggen, SH, Neale, MC, O'Neill, FA, Walsh, D, Kendler, KS (2005). Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. American Journal of Psychiatry 162, 1824–1832.
Funke, B, Finn, CT, Plocik, AM, Lake, S, DeRosse, P, Kane, JM, Kucherlapati, R, Malhotra, AK (2004). Association of the DTNBP1 locus with schizophrenia in a U.S. population. American Journal of Human Genetics 75, 891–898.
Gold, JM, Carpenter, C, Randolph, C, Goldberg, TE, Weinberger, DR (1997). Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry 54, 159–165.
Goldberg, TE, Straub, RE, Callicott, JH, Hariri, A, Mattay, VS, Bigelow, L, Coppola, R, Egan, MF, Weinberger, DR (2006). The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31, 2022–2032.
Hall, J, Whalley, HC, Job, DE, Baig, BJ, McIntosh, AM, Evans, KL, Thomson, PA, Porteous, DJ, Cunningham-Owens, DG, Johnstone, EC, Lawrie, SM (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nature Neuroscience 9, 1477–1478.
Hallmayer, JF, Kalaydjieva, L, Badcock, J, Dragovic, M, Howell, S, Michie, PT, Rock, D, Vile, D, Williams, R, Corder, EH, Hollingsworth, K, Jablensky, A (2005). Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. American Journal of Human Genetics 77, 468–476.
Harrison, PJ, Weinberger, DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40–68.
Härting, C, Markowitsch, H, Neufeld, H, Calabrese, P, Deisinger, K (2002). The Wechsler Memory Scale – Revised Edition [Wechlser Gedächtnis Test – Revidierte Fassung]. Hogrefe: Göttingen.
Jang, KL, Livesley, WJ, Vernon, PA (1996). Heritability of the big five personality dimensions and their facets: a twin study. Journal of Personality 64, 577–591.
Kendler, KS, Gruenberg, AM, Strauss, JS (1981). An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia. Archives of General Psychiatry 38, 982–984.
Kendler, KS, McGuire, M, Gruenberg, AM, O'Hare, A, Spellman, M, Walsh, D (1993). The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry 50, 527–540.
Kirov, G, Ivanov, D, Williams, NM, Preece, A, Nikolov, I, Milev, R, Koleva, S, Dimitrova, A, Toncheva, D, O'Donovan, MC, Owen, MJ (2004). Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent–offspring trios from Bulgaria. Biological Psychiatry 55, 971–975.
Krabbendam, L, Janssen, I, Bak, M, Bijl, RV, de Graaf, R, van Os, J (2002). Neuroticism and low self-esteem as risk factors for psychosis. Social Psychiatry and Psychiatric Epidemiology 37, 1–6.
Lehrl, S (2005). Multiple-choice Vocabulary Intelligence Test [Der Mehrfachwahl-Wortschatz-Intelligenztest]. Hogrefe: Göttingen.
Li, D, He, L (2007). Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophrenia Research 96, 112–118.
Lin, HF, Liu, YL, Liu, CM, Hung, SI, Hwu, HG, Chen, WJ (2005). Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents. Psychological Medicine 35, 1589–1598.
Maier, W, Minges, J, Lichtermann, D, Heun, R, Franke, P (1994). Personality variations in healthy relatives of schizophrenics. Schizophrenia Research 12, 81–88.
Mutsuddi, M, Morris, DW, Waggoner, SG, Daly, MJ, Scolnick, EM, Sklar, P (2006). Analysis of high-resolution HapMap of DTNBP1 (dysbindin) suggests no consistency between reported common variant associations and schizophrenia. American Journal of Human Genetics 79, 903–909.
Numakawa, T, Yagasaki, Y, Ishimoto, T, Okada, T, Suzuki, T, Iwata, N, Ozaki, N, Taguchi, T, Tatsumi, M, Kamijima, K, Straub, RE, Weinberger, DR, Kunugi, H, Hashimoto, R (2004). Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Human Molecular Genetics 13, 2699–2708.
O'Tuathaigh, CM, Babovic, D, O'Meara, G, Clifford, JJ, Croke, DT, Waddington, JL (2007). Susceptibility genes for schizophrenia: characterization of mutant mouse models at the level of phenotypic behavior. Neuroscience and Biobehavioral Reviews 31, 60–78.
Owen, MJ, O'Donovan, MC, Gottesman, II (2002). Schizophrenia. In Psychiatric Genetics and Genomics (ed. McGuffin, P., Owen, M. J. and Gottesman, I. I.), pp. 247–266. Oxford Medical Publishers: Oxford.
Owen, MJ, Williams, NM, O'Donovan, MC (2004 a). Dysbindin-1 and schizophrenia: from genetics to neuropathology. Journal of Clinical Investigation 113, 1255–1257.
Owen, MJ, Williams, NM, O'Donovan, MC (2004 b). The molecular genetics of schizophrenia: new findings promise new insights. Molecular Psychiatry 9, 14–27.
Posthuma, D, Luciano, M, Geus, EJ, Wright, MJ, Slagboom, PE, Montgomery, GW, Boomsma, DI, Martin, NG (2005). A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p. American Journal of Human Genetics 77, 318–326.
Raine, A, Benishay, D (1995). The SPQ-B: a brief screening instrument for schizotypal personality disorder. Journal of Personality Disorder 9, 346–355.
Reitan, RM, Wolfson, D (1985). The Halstead–Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychology Press: Tucson, AZ.
Schwab, SG, Knapp, M, Mondabon, S, Hallmayer, J, Borrmann-Hassenbach, M, Albus, M, Lerer, B, Rietschel, M, Trixler, M, Maier, W, Wildenauer, DB (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics 72, 185–190.
Smyrnis, N, Avramopoulos, D, Evdokimidis, I, Stefanis, CN, Tsekou, H, Stefanis, NC (2007). Effect of schizotypy on cognitive performance and its tuning by COMT val158met genotype variations in a large population of young men. Biological Psychiatry 61, 845–853.
Spitzer, RL, Endicott, J, Gibbon, M (1979). Crossing the border into borderline personality and borderline schizophrenia. The development of criteria. Archives of General Psychiatry 36, 17–24.
Stefanis, NC, Trikalinos, TA, Avramopoulos, D, Smyrnis, N, Evdokimidis, I, Ntzani, EE, Ioannidis, JP, Stefanis, CN (2007). Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biological Psychiatry 62, 784–792.
Stefanis, NC, Van Os, J, Avramopoulos, D, Smyrnis, N, Evdokimidis, I, Hantoumi, I, Stefanis, CN (2004). Variation in catechol-O-methyltransferase val158met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biological Psychiatry 56, 510–515.
Straub, RE, Jiang, Y, MacLean, CJ, Ma, Y, Webb, BT, Myakishev, MV, Harris-Kerr, C, Wormley, B, Sadek, H, Kadambi, B, Cesare, AJ, Gibberman, A, Wang, X, O'Neill, FA, Walsh, D, Kendler, KS (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics 71, 337–348.
Talbot, K, Eidem, WL, Tinsley, CL, Benson, MA, Thompson, EW, Smith, RJ, Hahn, CG, Siegel, SJ, Trojanowski, JQ, Gur, RE, Blake, DJ, Arnold, SE (2004). Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. Journal of Clinical Investigation 113, 1353–1363.
Tang, JX, Zhou, J, Fan, JB, Li, XW, Shi, YY, Gu, NF, Feng, GY, Xing, YL, Shi, JG, He, L (2003). Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Molecular Psychiatry 8, 717–718.
Torgersen, S, Edvardsen, J, Oien, PA, Onstad, S, Skre, I, Lygren, S, Kringlen, E (2002). Schizotypal personality disorder inside and outside the schizophrenic spectrum. Schizophrenia Research 54, 33–38.
Tosato, S, Ruggeri, M, Bonetto, C, Bertani, M, Marrella, G, Lasalvia, A, Cristofalo, D, Aprili, G, Tansella, M, Dazzan, P, Diforti, M, Murray, RM, Collier, DA (2007). Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 144B, 647–659.
Van Den Bogaert, A, Schumacher, J, Schulze, TG, Otte, AC, Ohlraun, S, Kovalenko, S, Becker, T, Freudenberg, J, Jonsson, EG, Mattila-Evenden, M, Sedvall, GC, Czerski, PM, Kapelski, P, Hauser, J, Maier, W, Rietschel, M, Propping, P, Nothen, MM, Cichon, S (2003). The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. American Journal of Human Genetics 73, 1438–1443.
van den Oord, EJ, Sullivan, PF, Jiang, Y, Walsh, D, O'Neill, FA, Kendler, KS, Riley, BP (2003). Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Molecular Psychiatry 8, 499–510.
Wechsler, D (1997). Wechsler Memory Scale: Administration and Scoring Manual. The Psychological Corporation/Harcourt Brace & Co.: San Antonio.
Weickert, CS, Straub, RE, McClintock, BW, Matsumoto, M, Hashimoto, R, Hyde, TM, Herman, MM, Weinberger, DR, Kleinman, JE (2004). Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Archives of General Psychiatry 61, 544–555.
Williams, NM, O'Donovan, MC, Owen, MJ (2005). Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophrenia Bulletin 31, 800–805.
Zinkstok, JR, de Wilde, O, van Amelsvoort, TA, Tanck, MW, Baas, F, Linszen, DH (2007). Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behavioral and Brain Functions 3, 19.